The rat growth hormone-releasing hormone receptor gene: Structure, regulation, and generation of receptor isoforms with different signaling properties

Endocrinology

Volumn 140, Issue 9, 1999, Pages 4152-4165

  Miller, Teresa L ^a   Godfrey, Paul A ^a   DeAlmeida, Venita I ^a   Mayo, Kelly E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GROWTH HORMONE RECEPTOR; SOMATOSTATIN;

ADENOHYPOPHYSIS; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CODON; EXON; GENE CONTROL; GENE MUTATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; GROWTH HORMONE RELEASE; HORMONE SYNTHESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR BINDING; RECEPTOR GENE; RNA PROCESSING; SIGNAL TRANSDUCTION; SOMATIC CELL GENETICS; TRANSCRIPTION REGULATION;

EID: 0033304980     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.9.6977     Document Type: Article

References (76)

1. Regulation of growth hormone secretion
2. Growth hormone-releasing hormone
3. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype
4. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1
5. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism
6. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency
7. Mutations in PROP1 cause familial combined pituitary hormone deficiency
8. Gsh-1, an orphan Hox gene, is required for normal pituitary development
9. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function
10. Molecular basis of the little mouse phenotype and implications for cell type-specific growth
11. Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone
12. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant
13. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene
14. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene
15. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro
16. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour
17. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly
18. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
19. The glucagon superfamily: Precursor structure and gene organization
20. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagon-like peptide 1, growth hormone-releasing hormone and glucagon belong to a newly discovered G protein-linked receptor family
21. Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth
22. Growth hormone-releasing hormone: Synthesis and signaling
23. Synthesis and expression of a gene for the rat glucagon receptor. Replacement of an aspartic acid in the extracellular domain prevents glucagon binding
24. Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP
25. Isolation, characterization, and chromosomal localization of the porcine calcitonin receptor gene. Identification of two variants of the receptor generated by alternative splicing
26. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene
27. Cloning and sequence analysis of the murine glucagon receptor-encoding gene
28. Genomic organization of the rat pituitary adenylate cydase-activating polypeptide receptor gene. Alternative splicing within the 5'-untranslated region
29. Differential signal transduction by five splice variants of the PACAP receptor
30. Human vaso-active intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways
31. Thyroid hormone regulates the mouse thyrotropin beta-subunit gene promoter in transfected primary thyrotropes
32. Isolation and characterization of the rat plasminogen activator inhibitor-1 gene
33. The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions
34. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression
35. Establishment of a series of pituitary clonal cell lines differing in morphology, hormone secretion, and response to estrogen
36. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
37. Primary structure of rat ribosomal protein S2. A ribosomal protein with arginine-glycine tandem repeats and RGGF motifs that are associated with nucleolar localization and binding to ribonucleic acids
38. Lipofection reagents prepared by a simple ethanol injection technique
39. Epitope tagging and protein surveillance
40. Use of a hybrid vaccina virus-T7 RNA polymerase system for expression of target genes
41. Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins
42. Intracellular calcium concentration and growth hormone secretion in individual somatotropes: Effects of growth hormone-releasing factor and somatostatin
43. The m3 muscarinic acetylcholine receptor differentially regulates calcium influx and release through modulation of monovalent cation channels
44. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse
45. The dwarfs of Sindh: Severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene
46. Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene
47. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly
48. Structure and regulation of the human growth hormone-releasing hormone receptor gene
49. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein
50. Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression
51. CCAAT/enhancer-binding protein alpha activation of the rat growth hormone promoter in pituitary progenitor GHFT1-5 cells
52. Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin beta-subunit promoter
53. Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene
54. The glucocorticoid receptor inhibits the human prolactin gene expression by interference with Pit-1 activity
55. Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen
56. Thyroid hormone and glucocorticoid regulation of pituitary growth hormone-releasing hormone receptor gene expression
57. Thyroid hormone regulation of gene expression of the pituitary growth hormone-releasing factor receptor
58. Sexually dimorphic expression of pituitary growth hormone-releasing factor receptor in the rat
59. Developmental regulation of pituitary growth hormone-releasing hormone receptor gene expression in the rat
60. Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels
61. Growth hormone-releasing factor (GRF) regulates expression of its own receptor
62. Defects in G protein-coupled signal transduction in human disease
63. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia
64. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes
65. Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript
66. Alterations in receptor activation and divalent cation activation of agonist binding by deletion of intracellar domains of the glucagon receptor
67. The PACAP receptor: Generation by alternative splicing of functional diversity among G protein-coupled receptors in nerve cells
68. Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channels
69. Identification of human growth hormone-releasing hormone receptor splicing variants
70. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas
71. Mutation of a putative amphipathic [alpha]-helix in the third intracellular domain of the platelet-activating factor receptor disrupts receptor/G protein coupling and signaling
72. Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop